Haemonetics | HAE - Loan Capital


Haemonetics reported $919.99M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Avanos Medical USD 90.3M 3.1M Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 10.99B 12M Sep/2025
Cerus USD 64.86M 22K Dec/2024
Cooper Companies USD 2.46B 26.1M Sep/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Fresenius Medical Care EUR 4.85B 4.49B Dec/2025
Globus Medical USD 427K 254K Sep/2025
Haemonetics USD 919.99M 406K Dec/2025
Hologic USD 2.5B 2.1M Dec/2025
ICU Medical USD 1.27B 48.01M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 559.1M 39.6M Sep/2025
Medtronic USD 27.62B 1.45B Sep/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Neogen USD 792.93M 396K Sep/2025
OraSure Technologies USD 0 0 Sep/2024
Plus Therapeutics USD 3.79M 322K Dec/2022
Quidel USD 2.47B 2.47B Dec/2025
ResMed USD 403.92M 4.74M Dec/2025
STAAR Surgical USD 42K 42K Dec/2023
Steris USD 1.9B 1.1M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Surmodics USD 29.55M 30K Sep/2024
Teleflex USD 2.54B 30.06M Dec/2025
Terumo JPY 99.9B 12M Dec/2025
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
US Physical Therapy USD 152.59M 1.13M Dec/2025
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025